GILD today
$169.25-$0.48 (-0.28%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourSymmetric Triangle
1 hourBearish
15 minBearish
5 minConsolidating
Daily trend turns down below $151.71
Key levels
Resistance$176.58
Support$160.51
Support$151.71
Latest news & SEC filings
AnalystArgus Research raises its price target on Gilead Sciences.
SEC FilingGilead Sciences, Inc. filed an insider trading report (Form 4)
ProductGilead reports positive study data for HIV prevention and liver disease
AnalystDaiwa Securities lifts its target on Gilead Sciences to $174 from $150
All GILD news →About Gilead Sciences
Gilead Sciences is a biopharmaceutical company that creates and sells medicines for serious illnesses such as HIV, hepatitis, COVID-19, and various cancers. Its products include antiviral therapies, cell-based cancer treatments, and an antifungal agent, sold to healthcare providers and patients through wholesalers, distributors, and its own commercial teams. The company operates in over 35 countries, with headquarters in Foster City, California.
Based on the company's 10-K filed Feb 24, 2026.
Nasdaq · Healthcare
GILEAD SCIENCES, INC. (GILD)
What Is the Price Target for GILD?
SEPT Low Target
$127.00
SEPT Mid Target
$175.00
SEPT High Target
$200.00
Analyst Consensus
$175.00
Is GILD a Buy or Sell Right Now?
Thesis
- •Revenue growing 2.4% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for GILD.
Start Free Trial →Is GILD Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$137.97
19
Moat Score
NONE
6/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with GILD?
Insider Signal
SELLING
0 buys / 6 sells (90d)
Congress Signal
BUYING
9 buys / 5 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| O'Day Daniel Patrick | director officer | Buy | 9,810 | $710K | Nov 5, 2026 |
| O'Day Daniel Patrick | director officer | Sale | 9,810 | $1.7M | Nov 5, 2026 |
| O'Day Daniel Patrick | director officer | Buy | 102,619 | $7.4M | Nov 4, 2026 |
| O'Day Daniel Patrick | director officer | Sale | 102,619 | $18.0M | Nov 4, 2026 |
| Mercier Johanna | officer | Sale | 3,000 | $469K | Oct 15, 2026 |
| Dickinson Andrew D | officer | Sale | 3,000 | $469K | Oct 15, 2026 |
| Burkhart Erin | officer | Buy | 2,223 | - | Sep 22, 2026 |
| Burkhart Erin | officer | Sale | 768 | $117K | Sep 22, 2026 |
| Cain Wettan Keeley M | officer | Buy | 590 | - | Sep 10, 2026 |
| Cain Wettan Keeley M | officer | Sale | 285 | $41K | Sep 10, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →GILD Growth Story
Revenue YoY
2.4%
3yr Revenue CAGR
2.6%
EPS Growth YoY
1684.21%
FCF Growth YoY
-8.2%
Revenue Trend
ACCELERATING
Dark Pool Trades for GILD
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for GILD, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:14:28 | $169.27 | 6,888 | $$1.2M | SELL |
| 19:50:47 | $169.09 | 1,045 | $$177K | BUY |
| 19:43:04 | $169.19 | 1,474 | $$249K | SELL |
| 18:31:52 | $169.95 | 1,185 | $$201K | BUY |
| 18:29:20 | $169.77 | 1,324 | $$225K | SELL |
5 dark pool trades shown · $$2.0M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for GILD
PREVIEWSEPT Investing provides real-time options flow tracking for GILD, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $180 | Mar 19 | 127 | $$1735 | 1 | SWEEP |
| PUT | $172.5 | Nov 20 | 8 | $$75.4K | 184 | BLOCK |
| CALL | $160 | Dec 18 | 36 | $$2700 | 2 | SWEEP |
| CALL | $170 | Jan 15 | 64 | $$1820 | 2 | SWEEP |
| CALL | $185 | Jan 15 | 64 | $$34.2K | 95 | SWEEP |
5 options trades shown · 60% calls
Unusual activity, GEX levels, max pain, and dealer positioning
What Traders Are Saying About GILD
1 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for GILD. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
SEPT Brain on $GILD -- Neutral Bounced back with 74% buying after prior session selling. Uptrend holds while above $127.10. $140 psychological level is the next resistance to watch. The Play: Watch ...
Join 3,500+ traders discussing GILD in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for GILEAD SCIENCES, INC. (GILD) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →GILD — frequently asked questions
What is GILD stock price today?
GILEAD SCIENCES, INC. (GILD) is at $169.25, down 0.28% (-$0.48) at the Nov 12, 2026 close.
Why is GILD stock moving today?
Latest GILD news — Nov 12, 2026: Argus Research raises its price target on Gilead Sciences. · Nov 9, 2026: Gilead Sciences, Inc. filed an insider trading report (Form 4)
Why did GILD stock move on Oct 29, 2026?
Gilead Sciences reported third-quarter 2026 adjusted EPS of $2.55 and sales of $8.300B, both beating analyst estimates of $2.19 and $7.809B. However, the company cut its FY2026 adjusted EPS outlook to a loss of $(1.20)-$(0.85) from $(0.65)-$(0.30) and reduced GAAP EPS guidance to $(4.40)-$(4.05), while lifting its FY2026 sales forecast to $31.000B-$31.300B from $30.100B-$30.400B.
What is the GILD price target?
The average analyst price target for GILD is $175.00, ranging from $127 to $200, based on 15 analysts. Latest: Maxim Group raises on Nov 5, 2026.
What do analysts rate GILD?
Analyst ratings for GILD: 1 Buy, 29 Hold, 2 Sell — consensus Hold.
Did GILD beat earnings?
GILD last reported on Oct 29, 2026: EPS $2.55 vs $2.19 expected — a beat of 16.4%.
Does GILD pay a dividend?
Yes. GILD's dividend yield is 2.62%.
What are GILD support and resistance levels?
Support: $160.51, $151.71, $142.60. Resistance: $176.58.
What are insiders doing with GILD?
Insider activity: SELLING, 0 buys and 6 sells in the last 90 days.
What is the latest news on GILD?
Nov 12, 2026: Argus Research raises its price target on Gilead Sciences. · Nov 9, 2026: Gilead Sciences, Inc. filed an insider trading report (Form 4) · Nov 9, 2026: Gilead reports positive study data for HIV prevention and liver disease